32660586|t|Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learning.
32660586|a|BACKGROUND: P301S tau transgenic mice show age-dependent accumulation of neurofibrillary tangles in the brainstem, hippocampus, and neocortex, leading to neuronal loss and cognitive deterioration. However, there is hitherto only sparse documentation of the role of neuroinflammation in tau mouse models. Thus, we analyzed longitudinal microglial activation by small animal 18 kDa translocator protein positron-emission-tomography (TSPO muPET) imaging in vivo, in conjunction with terminal assessment of tau pathology, spatial learning, and cerebral glucose metabolism. METHODS: Transgenic P301S (n = 33) and wild-type (n = 18) female mice were imaged by 18F-GE-180 TSPO muPET at the ages of 1.9, 3.9, and 6.4 months. We conducted behavioral testing in the Morris water maze, 18F-fluordesoxyglucose (18F-FDG) muPET, and AT8 tau immunohistochemistry at 6.3-6.7 months. Terminal microglial immunohistochemistry served for validation of TSPO muPET results in vivo, applying target regions in the brainstem, cortex, cerebellum, and hippocampus. We compared the results with our historical data in amyloid-beta mouse models. RESULTS: TSPO expression in all target regions of P301S mice increased exponentially from 1.9 to 6.4 months, leading to significant differences in the contrasts with wild-type mice at 6.4 months (+ 11-23%, all p < 0.001), but the apparent microgliosis proceeded more slowly than in our experience in amyloid-beta mouse models. Spatial learning and glucose metabolism of AT8-positive P301S mice were significantly impaired at 6.3-6.5 months compared to the wild-type group. Longitudinal increases in TSPO expression predicted greater tau accumulation and lesser spatial learning performance at 6.3-6.7 months. CONCLUSIONS: Monitoring of TSPO expression as a surrogate of microglial activation in P301S tau transgenic mice by muPET indicates a delayed time course when compared to amyloid-beta mouse models. Detrimental associations of microglial activation with outcome parameters are opposite to earlier data in amyloid-beta mouse models. The contribution of microglial response to pathology accompanying amyloid-beta and tau over-expression merits further investigation.
32660586	13	17	TSPO	Gene	12257
32660586	47	52	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;OriginalGene:12257;CorrespondingGene:706;CorrespondingSpecies:10090
32660586	53	57	mice	Species	10090
32660586	98	127	deteriorated spatial learning	Disease	MESH:D007859
32660586	141	146	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;OriginalGene:12257;CorrespondingGene:706;CorrespondingSpecies:10090
32660586	151	166	transgenic mice	Species	10090
32660586	202	225	neurofibrillary tangles	Disease	MESH:D055956
32660586	283	296	neuronal loss	Disease	MESH:D009410
32660586	301	324	cognitive deterioration	Disease	MESH:D003072
32660586	394	411	neuroinflammation	Disease	MESH:D000090862
32660586	419	424	mouse	Species	10090
32660586	502	508	18 kDa	Gene	56529
32660586	509	529	translocator protein	Gene	12257
32660586	560	564	TSPO	Gene	12257
32660586	678	685	glucose	Chemical	MESH:D005947
32660586	718	723	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;OriginalGene:12257;CorrespondingGene:706;CorrespondingSpecies:10090
32660586	763	767	mice	Species	10090
32660586	783	793	18F-GE-180	Chemical	-
32660586	794	798	TSPO	Gene	12257
32660586	904	926	18F-fluordesoxyglucose	Chemical	-
32660586	928	935	18F-FDG	Chemical	-
32660586	937	942	muPET	Chemical	-
32660586	1062	1066	TSPO	Gene	12257
32660586	1234	1239	mouse	Species	10090
32660586	1257	1261	TSPO	Gene	12257
32660586	1298	1303	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;OriginalGene:12257;CorrespondingGene:706;CorrespondingSpecies:10090
32660586	1304	1308	mice	Species	10090
32660586	1424	1428	mice	Species	10090
32660586	1487	1499	microgliosis	Disease	
32660586	1561	1566	mouse	Species	10090
32660586	1596	1603	glucose	Chemical	MESH:D005947
32660586	1631	1636	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;OriginalGene:12257;CorrespondingGene:706;CorrespondingSpecies:10090
32660586	1637	1641	mice	Species	10090
32660586	1747	1751	TSPO	Gene	12257
32660586	1781	1784	tau	Disease	MESH:C536599
32660586	1884	1888	TSPO	Gene	12257
32660586	1943	1948	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;OriginalGene:12257;CorrespondingGene:706;CorrespondingSpecies:10090
32660586	1953	1968	transgenic mice	Species	10090
32660586	1972	1977	muPET	Chemical	-
32660586	2040	2045	mouse	Species	10090
32660586	2173	2178	mouse	Species	10090
32660586	Association	MESH:D005947	HGVS:p.P301S;CorrespondingGene:706
32660586	Positive_Correlation	MESH:D055956	HGVS:p.P301S;CorrespondingGene:706
32660586	Positive_Correlation	MESH:D003072	HGVS:p.P301S;CorrespondingGene:706
32660586	Association	MESH:D007859	12257
32660586	Association	MESH:D007859	HGVS:p.P301S;CorrespondingGene:706
32660586	Association	MESH:C536599	12257
32660586	Association	MESH:D055956	706
32660586	Association	MESH:D003072	706
32660586	Association	MESH:D007859	706

